Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells.
Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells. Oncotarget. 2015 Oct 06; 6(30):30072-87.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Blotting, Western
Carcinoma, Non-Small-Cell Lung
Cation Transport Proteins
Cell Cycle
Cell Line, Tumor
Cell Survival
Cisplatin
DNA Repair
Dose-Response Relationship, Drug
Drug Resistance, Neoplasm
Humans
Lung Neoplasms
Mice
Mice, Nude
Microscopy, Fluorescence
Mutation
NIH 3T3 Cells
Proto-Oncogene Proteins p21(ras)
Reverse Transcriptase Polymerase Chain Reaction
Xenograft Model Antitumor Assays
authors with profiles
Marina Chiara Garassino